Jeffrey Chapman, MD, is a Staff Physician in the Department of Pulmonary, Allergy and Critical Care Medicine and the Transplantation Center. His specialty interests include interstitial lung disease, idiopathic pulmonary fibrosis, lung transplantation and advanced lung disease.

Dr. Chapman earned his medical degree from Washington University School of Medicine in St. Louis, Mo. He completed an internship and residency in internal medicine, as well as a fellowship at New York Presbyterian Hospital, Columbia Presbyterian Campus in New York. He also completed a fellowship in pulmonary and critical care medicine at Yale-New Haven Hospital in New Haven, Conn.

He is a Diplomate in Critical Care Medicine, Pulmonary Disease and Internal Medicine with through the American Board of Internal Medicine, as well as a Diplomate with the National Board of Medical Examiners.

He is a member of the Society of Critical Care Medicine, an American College of Chest Physicians Fellow and a member of the American Thoracic Society.

Dr. Chapman has published a number of articles in peer-reviewed journals on topics such as transplantation, sleep-related breathing disorders and lung disease, among many others.

Fellowship - Yale-New Haven Hospital

Pulmonary & Critical Care Medi
New Haven, CT USA
2000

Fellowship - New York Presbyterian Hospital, Columbia Presbyterian Campus

Pulmonary & Critical Care Medi
New York, NY USA
1996

Residency - New York Presbyterian Hospital, Columbia Presbyterian Campus

Internal Medicine
New York, NY USA
1995

Medical School - Washington University School of Medicine

St. Louis, MO USA
1992

Undergraduate - Northwestern University

Evanston, IL USA
1988

• Internal Medicine- Pulmonary Disease

• American Thoracic Society
• American College of Chest Physicians

• Diagnosing Asthma
• Lung Transplantation
• Treating Asthma With Bronchodialators

• Advanced Lung Disease
• Asthma
• Interstitial Lung Disease
• Langerhans Cell Histiocytosis (LCH)
• Lymphangioleiomyomatosis (LAM)
• Pneumonia
• Pulmonary Fibrosis
• Sarcoidosis
• Wegener's Granulomatosis

Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/4/2008, Dr. Chapman has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

• English